Join to view full profile
101 Manning DriveChapel Hill, NC 27514
Dr. Abdou is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of New Mexico School of MedicineResidency, Internal Medicine, 2014 - 2017
Jordan University of Science and Technology FOMClass of 2012
Certifications & Licensure
NC State Medical License 2020 - 2027
NY State Medical License 2019 - 2021
NM State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC Start of enrollment: 2020 Jul 20
Roles: Principal Investigator, Contact
- Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer Start of enrollment: 2019 Jul 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007).Yara Abdou, Jess Hoag, William E Barlow, Kathy S Albain, Julie R Gralow
Journal of the National Cancer Institute. 2026-10-01 - Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).Yara Abdou, Mariya Rozenblit, Dario Trapani, Ioannis Zerdes, Erin Boudreau
NPJ Breast Cancer. 2026-05-11 - Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World Studies.Silvio Matsas, Julita Zembala, Anderson Ruiz Simões, Luiza Giuliani Schmitt, Yara Abdou
Asian Pacific Journal of Cancer Prevention. 2026-03-01
Press Mentions
Special Session to Explore Biology, Treatment of Breast Cancer in Young WomenNovember 3rd, 2025- Exact Sciences Corp. - JAMA Oncology Publication Strengthens Evidence for Oncotype DX Test Reliability Across Racial and Ethnic GroupsApril 15th, 2025
- JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic GroupsApril 14th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: